New England Private Wealth Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
New England Private Wealth Advisors's PFE Position: Q4 2019 in Review
New England Private Wealth Advisors sold out of Pfizer (PFE) in Q4 2019, closing a stake of 18,880 shares — an estimated $644K sold.
New England Private Wealth Advisors first reported a position in PFE in Q2 2013 and held it in 26 quarters. The position peaked at $845K in Q1 2019. 2,526 funds tracked by Wall St. Rank hold PFE as of Q4 2019.
- New England Private Wealth Advisors reported no remaining Pfizer position as of Q4 2019 after selling out during the quarter.
- New England Private Wealth Advisors sold 18,880 Pfizer shares in Q4 2019, an estimated $644K.
- New England Private Wealth Advisors first reported a position in Pfizer in Q2 2013 and held it in 26 quarters.
- New England Private Wealth Advisors's Pfizer position peaked at $845K in Q1 2019.
- 2,526 funds tracked by Wall St. Rank held Pfizer as of Q4 2019.
Based on New England Private Wealth Advisors's 13F filing for Q4 2019, filed 11 Feb 2020.